Rise and shine. A sunny day is unfolding here on the Pharmalot corporate campus, where we are happily quaffing another cup of stimulation. This makes it easier to attack that growing list of meetings and deadlines. We trust you can relate.By the way, we are hosting a June 21 webinar on using Social Media for gathering intelligence and research and invite you to join us ( look here). Meanwhile, here are some interesting tidbits. Have a great day, everyone...
Sanofi Starts To Put Its Stamp On Genzyme (The Boston Globe)
Regeneron Eye Drug Will Rival Lucentis (Bloomberg News)
J&J Cuts Back On Stent Sales And Eliminates 1,000 Jobs (Associated Press)
Ipierian Shake Up Continues With High-Profile Departures (Xconomy)
Merck And AstraZeneca Team To Test Cancer Meds (Bloomberg News)
Biotech Founder John Crowley Considers Run For US Senate (Associated Press)
Indian Drug Regulator Calls For Central Pricing (Pharma Times)
Pfizer To Get $2M Tax Refund From New York Suburb (Nyack Patch)
Claris Expects To Resolve FDA Issues This Year (Dow Jones)
Swiss Stock Exchange Probes Synthes Trading Before J&J Takeover (Reuters)
US And EU Link Faster R&D Initiatives (Pharma Times)
Glaxo Expands Ontario Plant And Adds 70 Jobs (InPharma Technologist)
EDITOR’S NOTE: Please check this post for updates throughout the morning